Source author record

Gaurav Pachpute

Gaurav Pachpute appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
3topics
2close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2011arXiv

Analysis of Hepatitis C Viral Dynamics Using Latin Hypercube Sampling

We consider a mathematical model comprising of four coupled ordinary differential equations (ODEs) for studying the hepatitis C (HCV) viral dynamics. The model embodies the efficacies of a combination therapy of interferon and ribavirin. A condition for the stability of the uninfected and the infected steady states is presented. A large number of sample points for the model parameters (which were physiologically feasible) were generated using Latin hypercube sampling. Analysis of our simulated values indicated approximately 24% cases as having an uninfected steady state. Statistical tests like the chi-square-test and the Spearman's test were also done on the sample values. The results of these tests indicate a distinctly differently distribution of certain parameter values and not in case of others, vis-a-vis, the stability of the uninfected and the infected steady states.

preprint2011arXiv

Free Final-Time Optimal Control for HIV Viral Dynamics

In this paper, we examine a well-established model for HIV wild-type infection. The algorithm for steepest descent method for fixed final-time is stated and a modified method for free final-time is presented. The first type of cost functional considered, seeks to minimize the total time of therapy. An easy implementation for this problem suggests that it can be effective in the early stages of treatment as well as for individual-based studies, due to the "hit first and hit hard" nature of optimal control. An LQR based cost functional is also presented and the solution is found using steepest descent method. It suggests that the optimal therapy must remain high until the patient shows signs of recovery after which, the therapy gradually decreases. This is in line with the biomedical philosophy. Solution to a modified problem which includes a weight for total time is approximated using the modified algorithm. It shows a considerable drop in the total period. We conclude that, a decreased and optimized therapy period can help us increase efficiency as well as the turnover rate for patient care.

preprint2011arXiv

Optimal Therapy of Hepatitis C Dynamics and Sampling Based Analysis

We examine two models for hepatitis C viral (HCV) dynamics, one for monotherapy with interferon (IFN) and the other for combination therapy with IFN and ribavirin. Optimal therapy for both the models is determined using the steepest gradient method, by defining an objective functional which minimizes the infected hepatocyte levels, virion population and the side-effects of the drug(s). The optimal therapy for both the models shows an initial period of high efficacy, followed by a gradual decline. The period of high efficacy coincides with a significant decrease in the infected hepatocyte levels as well as viral load, whereas the efficacy drops after liver regeneration through restored hepatocyte levels. The period of high efficacy is not altered significantly when the cost coefficients are varied, as long as the side effects are relatively small. This suggests a higher dependence of the optimal therapy on the model parameters in case of drugs with minimal side effects. We use the Latin hypercube sampling technique to randomly generate a large number of patient scenarios (i.e, model parameter sets) and study the dynamics of each set under the optimal therapy already determined. Results show an increase in the percentage of responders (as indicated by drop in viral load below detection levels) in case of combination therapy as compared to monotherapy. Statistical tests performed to study the correlations between sample parameters and the time required for the viral load to fall below detection level, show a strong monotonic correlation with the death rate of infected hepatocytes, identifying it to be an important factor in deciding individual drug regimens.